A Multiple Dose Study of the Safety, Tolerability and PK of CMX157 in Healthy Subjects
Clinical trial NCT02585440 · COMPLETED
Trial details
- NCT number
- NCT02585440
- Sponsor
- ContraVir Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2016-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.